Rasagiline Mesylate Sublingual membrane(Shanghai Shangyao Zhongxi Pharma)

甲磺酸雷沙吉兰舌下膜(上海上药中西制药)

Report date: 2025/08/08 14:14:25

Base Information

Drug NameRasagiline Mesylate Sublingual membrane(Shanghai Shangyao Zhongxi Pharma)
Drug Alias NameRasagilinum雷萨吉兰甲磺酸盐rasagilina雷沙吉兰甲烷磺酸盐Rasagiline Mesilate +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A